Anatibant 2HCl

TargetMol
Product Code: TAR-T26627L
Supplier: TargetMol
CodeSizePrice
TAR-T26627L-1mg1mg£352.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26627L-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26627L-10mg10mg£1,034.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26627L-25mg25mg£1,348.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26627L-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26627L-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
Anatibant 2HCl is a small molecule bradykinin B2 receptor antagonist for the treatment of neurological disorders and may be used in the study of brain injury.
CAS:
209788-45-4
Molecular Weight:
784.58
Pathway:
GPCR/G Protein
Purity:
0.9918
SMILES:
ClC(C(S(=O)(N1[C@@H](CCC1)C(NCCCNC(C2=CC=C(C=C2)C(N)=N)=O)=O)=O)=CC=C3Cl)=C3COC4=CC=CC5=C4N=C(C)C=C5C.Cl.Cl
Target:
Bradykinin Receptor

References

Kl?sner B, et al. Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats. Neurochem Int. 2006;49(5):442-447. Zweckberger K, et al. Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury. Neurosci Lett. 2009;454(2):115-117. Ongali B, et al. Autoradiographic analysis of mouse brain kinin B1 and B2 receptors after closed head trauma and ability of Anatibant mesylate to cross the blood-brain barrier. J Neurotrauma. 2006;23(5):696-707.